York's Dinan Ackman's Latest Investor Enemy

Mar 11 2013 | 10:52am ET

Pershing Square Capital Management's William Ackman has a new peer-adversary.

Already sparring with longtime nemesis Carl Icahn over nutritional supplements company Herbalife—which Ackman calls a "pyramid scheme" and Icahn an opportunity—Ackman now finds himself opposing York Capital Management's James Dinan on retailer JC Penney Corp.

In an inversion of the Herbalife situation, Ackman is extremely bullish on Penney, while Dinan said last week that York is shorting the company's debt. He also gently criticized Ackman and other activists, noting that activism "works great when the tide is rising." But he said that Ackman faces trouble, given Vornado Realty Trust's recent sale of half of its Penney stake, Reuters reports.

Ackman has been investing in Penney since 2010. The retailer's stock price has been falling, and its CEO, former Apple Inc. executive Ron Johnson, was recently forced to abandon his signature program at Penney, an end to sales.

Pershing Square is currently nursing a loss on its Penney holdings.


In Depth

Q&A: Sancus Capital And The Disruption Of The CLO Market

Oct 5 2017 | 6:28pm ET

Traditional collateralized loan obligation (CLO) funds in the U.S. market can offer...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Finding Success as Alternatives Converge

Oct 9 2017 | 4:00pm ET

Rising interest among institutional investors over the past several years has led...

 

From the current issue of